Clinical Trial Update: Comparison of the 3-month Strut Coverage After Coronary Stenting by Optical Coherence Tomography; Cilotax and DESyne [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing 3-month stent strut coverage using optical coherence tomography for Cilotax and DESyne has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cilotax
• DESyne

Snippet

Sponsor: Yonsei University | Conditions: Patients in the Treatment of Subjects With All-comer Who Are to Undergo PCI | Phase 4 | Status: WITHDRAWN